Influence of S-1108 on intestinal bacterial flora

S. Iwata, K. Kawahara, E. Isohata, Y. Kin, K. Yokota, Y. Kusumoto, Y. Sato, H. Akita, T. Oikawa, K. Sunakawa, Y. Ichihashi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effect of S-1108, a new oral cephem antibiotic, on intestinal bacterial flora was studied in tetra-contaminated mice and pediatric patients. S-1108 in a fine granular form was administred at a dose of 15 mg/kg once a day for 5 consecutive days to mice infected with Escherichia coli, Enterococcus faecalis, Bacteroides fragilis and Bifidobacterium breve. The viable fecal bacterial cell count of each of these 4 species of bacteria was slightly reduced in 5 days after the start of the drug administration. Five boys (weighing 12.0 to 42.0 kg) with bacterial infections were entered into this pediatric study. Their ages ranged from 2 years 4 months to 9 years 3 months. S-1108 (fine granules) was administered at a dose of 2.3 to 6.0 mg/kg, 3 times a day for 5 to 11 days. Cell counts of primary aerobes, anaerobes and total anaerobic cells decreased markedly in three patients, but in the remaining two patients the total number of aerobic and anaerobic cells did not change appreciably. Glucose-nonfermentating Gram-negative rods did not become predominant during the period of S-1108 administration. Candida became predominant in the three patients in whom the other bacteria had markedly decreased. Counts of predominant aerobic and anaerobic bacteria decreased markedly during the regimen in 3 out of 5 cases. S-1006 was detected in stools of the 3 cases at concentrations ranging from 235 to 516 μg/g during the administration of S-1108. Intestial bacteria that produce β-lactamase were not present in the feces of any of the patients. Based on these results, S-1108 (fine granules) appears to have relatively little effect on intestinal bacterial flora similarly to other new oral cephems. Because of individual differences, however, the drug may be excreted in the feces at high concentrations, and this would result in changes in intestinal bacterial flora. Therefore, attention must be given to fecal drug concentrations.

Original languageEnglish
Pages (from-to)1045-1062
Number of pages18
JournalJapanese Journal of Antibiotics
Volume46
Issue number12
Publication statusPublished - 1993

Fingerprint

S 1108
Bacteria
Feces
Cell Count
Pharmaceutical Preparations
Pediatrics
Bacteroides fragilis
Aerobic Bacteria
Anaerobic Bacteria
Bacterial Load
Enterococcus faecalis
Candida
Bacterial Infections
Individuality
Gastrointestinal Microbiome
Escherichia coli
Anti-Bacterial Agents
Glucose

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Iwata, S., Kawahara, K., Isohata, E., Kin, Y., Yokota, K., Kusumoto, Y., ... Ichihashi, Y. (1993). Influence of S-1108 on intestinal bacterial flora. Japanese Journal of Antibiotics, 46(12), 1045-1062.

Influence of S-1108 on intestinal bacterial flora. / Iwata, S.; Kawahara, K.; Isohata, E.; Kin, Y.; Yokota, K.; Kusumoto, Y.; Sato, Y.; Akita, H.; Oikawa, T.; Sunakawa, K.; Ichihashi, Y.

In: Japanese Journal of Antibiotics, Vol. 46, No. 12, 1993, p. 1045-1062.

Research output: Contribution to journalArticle

Iwata, S, Kawahara, K, Isohata, E, Kin, Y, Yokota, K, Kusumoto, Y, Sato, Y, Akita, H, Oikawa, T, Sunakawa, K & Ichihashi, Y 1993, 'Influence of S-1108 on intestinal bacterial flora', Japanese Journal of Antibiotics, vol. 46, no. 12, pp. 1045-1062.
Iwata S, Kawahara K, Isohata E, Kin Y, Yokota K, Kusumoto Y et al. Influence of S-1108 on intestinal bacterial flora. Japanese Journal of Antibiotics. 1993;46(12):1045-1062.
Iwata, S. ; Kawahara, K. ; Isohata, E. ; Kin, Y. ; Yokota, K. ; Kusumoto, Y. ; Sato, Y. ; Akita, H. ; Oikawa, T. ; Sunakawa, K. ; Ichihashi, Y. / Influence of S-1108 on intestinal bacterial flora. In: Japanese Journal of Antibiotics. 1993 ; Vol. 46, No. 12. pp. 1045-1062.
@article{31d25e7e1d3742e680ff99e4a58d66d2,
title = "Influence of S-1108 on intestinal bacterial flora",
abstract = "The effect of S-1108, a new oral cephem antibiotic, on intestinal bacterial flora was studied in tetra-contaminated mice and pediatric patients. S-1108 in a fine granular form was administred at a dose of 15 mg/kg once a day for 5 consecutive days to mice infected with Escherichia coli, Enterococcus faecalis, Bacteroides fragilis and Bifidobacterium breve. The viable fecal bacterial cell count of each of these 4 species of bacteria was slightly reduced in 5 days after the start of the drug administration. Five boys (weighing 12.0 to 42.0 kg) with bacterial infections were entered into this pediatric study. Their ages ranged from 2 years 4 months to 9 years 3 months. S-1108 (fine granules) was administered at a dose of 2.3 to 6.0 mg/kg, 3 times a day for 5 to 11 days. Cell counts of primary aerobes, anaerobes and total anaerobic cells decreased markedly in three patients, but in the remaining two patients the total number of aerobic and anaerobic cells did not change appreciably. Glucose-nonfermentating Gram-negative rods did not become predominant during the period of S-1108 administration. Candida became predominant in the three patients in whom the other bacteria had markedly decreased. Counts of predominant aerobic and anaerobic bacteria decreased markedly during the regimen in 3 out of 5 cases. S-1006 was detected in stools of the 3 cases at concentrations ranging from 235 to 516 μg/g during the administration of S-1108. Intestial bacteria that produce β-lactamase were not present in the feces of any of the patients. Based on these results, S-1108 (fine granules) appears to have relatively little effect on intestinal bacterial flora similarly to other new oral cephems. Because of individual differences, however, the drug may be excreted in the feces at high concentrations, and this would result in changes in intestinal bacterial flora. Therefore, attention must be given to fecal drug concentrations.",
author = "S. Iwata and K. Kawahara and E. Isohata and Y. Kin and K. Yokota and Y. Kusumoto and Y. Sato and H. Akita and T. Oikawa and K. Sunakawa and Y. Ichihashi",
year = "1993",
language = "English",
volume = "46",
pages = "1045--1062",
journal = "The Journal of antibiotics. Ser. B",
issn = "0368-2781",
publisher = "Japan Antibiotics Research Association",
number = "12",

}

TY - JOUR

T1 - Influence of S-1108 on intestinal bacterial flora

AU - Iwata, S.

AU - Kawahara, K.

AU - Isohata, E.

AU - Kin, Y.

AU - Yokota, K.

AU - Kusumoto, Y.

AU - Sato, Y.

AU - Akita, H.

AU - Oikawa, T.

AU - Sunakawa, K.

AU - Ichihashi, Y.

PY - 1993

Y1 - 1993

N2 - The effect of S-1108, a new oral cephem antibiotic, on intestinal bacterial flora was studied in tetra-contaminated mice and pediatric patients. S-1108 in a fine granular form was administred at a dose of 15 mg/kg once a day for 5 consecutive days to mice infected with Escherichia coli, Enterococcus faecalis, Bacteroides fragilis and Bifidobacterium breve. The viable fecal bacterial cell count of each of these 4 species of bacteria was slightly reduced in 5 days after the start of the drug administration. Five boys (weighing 12.0 to 42.0 kg) with bacterial infections were entered into this pediatric study. Their ages ranged from 2 years 4 months to 9 years 3 months. S-1108 (fine granules) was administered at a dose of 2.3 to 6.0 mg/kg, 3 times a day for 5 to 11 days. Cell counts of primary aerobes, anaerobes and total anaerobic cells decreased markedly in three patients, but in the remaining two patients the total number of aerobic and anaerobic cells did not change appreciably. Glucose-nonfermentating Gram-negative rods did not become predominant during the period of S-1108 administration. Candida became predominant in the three patients in whom the other bacteria had markedly decreased. Counts of predominant aerobic and anaerobic bacteria decreased markedly during the regimen in 3 out of 5 cases. S-1006 was detected in stools of the 3 cases at concentrations ranging from 235 to 516 μg/g during the administration of S-1108. Intestial bacteria that produce β-lactamase were not present in the feces of any of the patients. Based on these results, S-1108 (fine granules) appears to have relatively little effect on intestinal bacterial flora similarly to other new oral cephems. Because of individual differences, however, the drug may be excreted in the feces at high concentrations, and this would result in changes in intestinal bacterial flora. Therefore, attention must be given to fecal drug concentrations.

AB - The effect of S-1108, a new oral cephem antibiotic, on intestinal bacterial flora was studied in tetra-contaminated mice and pediatric patients. S-1108 in a fine granular form was administred at a dose of 15 mg/kg once a day for 5 consecutive days to mice infected with Escherichia coli, Enterococcus faecalis, Bacteroides fragilis and Bifidobacterium breve. The viable fecal bacterial cell count of each of these 4 species of bacteria was slightly reduced in 5 days after the start of the drug administration. Five boys (weighing 12.0 to 42.0 kg) with bacterial infections were entered into this pediatric study. Their ages ranged from 2 years 4 months to 9 years 3 months. S-1108 (fine granules) was administered at a dose of 2.3 to 6.0 mg/kg, 3 times a day for 5 to 11 days. Cell counts of primary aerobes, anaerobes and total anaerobic cells decreased markedly in three patients, but in the remaining two patients the total number of aerobic and anaerobic cells did not change appreciably. Glucose-nonfermentating Gram-negative rods did not become predominant during the period of S-1108 administration. Candida became predominant in the three patients in whom the other bacteria had markedly decreased. Counts of predominant aerobic and anaerobic bacteria decreased markedly during the regimen in 3 out of 5 cases. S-1006 was detected in stools of the 3 cases at concentrations ranging from 235 to 516 μg/g during the administration of S-1108. Intestial bacteria that produce β-lactamase were not present in the feces of any of the patients. Based on these results, S-1108 (fine granules) appears to have relatively little effect on intestinal bacterial flora similarly to other new oral cephems. Because of individual differences, however, the drug may be excreted in the feces at high concentrations, and this would result in changes in intestinal bacterial flora. Therefore, attention must be given to fecal drug concentrations.

UR - http://www.scopus.com/inward/record.url?scp=0027743016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027743016&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 1045

EP - 1062

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

SN - 0368-2781

IS - 12

ER -